These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 3007497

  • 21. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
    Gespach C, Bawab W, de Cremoux P, Calvo F.
    Cancer Res; 1988 Sep 15; 48(18):5079-83. PubMed ID: 2842044
    [Abstract] [Full Text] [Related]

  • 22. Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29.
    Couvineau A, Rousset M, Laburthe M.
    Biochem J; 1985 Oct 01; 231(1):139-43. PubMed ID: 2998337
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. VIP receptor subtypes in mouse cerebral cortex: evidence for a differential localization in astrocytes, microvessels and synaptosomal membranes.
    Martin JL, Feinstein DL, Yu N, Sorg O, Rossier C, Magistretti PJ.
    Brain Res; 1992 Jul 31; 587(1):1-12. PubMed ID: 1326373
    [Abstract] [Full Text] [Related]

  • 26. Evidence for vasoactive intestinal peptide receptors in apical membranes from tracheal epithelium.
    Elgavish A, Pillion DJ, Meezan E.
    Life Sci; 1989 Jul 31; 44(15):1037-42. PubMed ID: 2538697
    [Abstract] [Full Text] [Related]

  • 27. Purification of monoiodinated vasointestinal peptide (M125I-VIP) by high pressure liquid chromatography (HPLC).
    Marie JC, Boissard C, Rosselin G.
    Peptides; 1984 Jul 31; 5(2):179-82. PubMed ID: 6089129
    [Abstract] [Full Text] [Related]

  • 28. Molecular characteristics and evidence for internalization of vasoactive-intestinal-peptide (VIP) receptors in the tumoral rat-pancreatic acinar cell line AR 4-2 J.
    Svoboda M, De Neef P, Tastenoy M, Christophe J.
    Eur J Biochem; 1988 Oct 01; 176(3):707-13. PubMed ID: 2844535
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Homogeneous [mono-125I-Tyr10]- and [mono-125I-Tyr13] glucagon.
    Pingoud V.
    J Chromatogr; 1985 Aug 30; 331(1):125-32. PubMed ID: 4044734
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A novel vasoactive intestinal peptide (VIP) from elasmobranch intestine has full affinity for mammalian pancreatic VIP receptors.
    Dimaline R, Young J, Thwaites DT, Lee CM, Shuttleworth TJ, Thorndyke MC.
    Biochim Biophys Acta; 1987 Aug 19; 930(1):97-100. PubMed ID: 2441759
    [Abstract] [Full Text] [Related]

  • 33. The preparation of bioactive 125I-gastrin, using Iodo-gen as oxidizing agent, and the use of this tracer in receptor studies.
    Kleveland PM, Haugen SE, Waldum HL.
    Scand J Gastroenterol; 1985 Jun 19; 20(5):569-76. PubMed ID: 2992067
    [Abstract] [Full Text] [Related]

  • 34. Purification of vasoactive intestinal peptide receptor from porcine liver by a newly designed one-step affinity chromatography.
    Couvineau A, Voisin T, Guijarro L, Laburthe M.
    J Biol Chem; 1990 Aug 05; 265(22):13386-90. PubMed ID: 2165502
    [Abstract] [Full Text] [Related]

  • 35. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas.
    Le Meuth V, Farjaudon N, Bawab W, Chastre E, Rosselin G, Guilloteau P, Gespach C.
    Am J Physiol; 1991 Feb 05; 260(2 Pt 1):G265-74. PubMed ID: 1847591
    [Abstract] [Full Text] [Related]

  • 36. Characterization and localization of vasoactive intestinal peptide receptors in the rat lung.
    Leroux P, Vaudry H, Fournier A, St-Pierre S, Pelletier G.
    Endocrinology; 1984 May 05; 114(5):1506-12. PubMed ID: 6325122
    [Abstract] [Full Text] [Related]

  • 37. Molecular identification of receptors for vasoactive intestinal peptide in rat intestinal epithelium by covalent cross-linking. Evidence for two classes of binding sites with different structural and functional properties.
    Laburthe M, Breant B, Rouyer-Fessard C.
    Eur J Biochem; 1984 Feb 15; 139(1):181-7. PubMed ID: 6321173
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Preferential binding of vasoactive intestinal polypeptide to basolateral membrane of rat and rabbit enterocytes.
    Dharmsathaphorn K, Harms V, Yamashiro DJ, Hughes RJ, Binder HJ, Wright EM.
    J Clin Invest; 1983 Jan 15; 71(1):27-35. PubMed ID: 6294141
    [Abstract] [Full Text] [Related]

  • 40. Preparation of 125I-labeled human growth hormone of high quality binding properties endowed with long-term stability.
    Biscayart PL, Paladini AC, Vita N, Roguin LP.
    J Immunoassay; 1989 Jan 15; 10(1):37-56. PubMed ID: 2715346
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.